Why the study?
Does morning versus evening statin administration improve LDL-C lowering in patients requiring statin therapy?
Does morning versus evening statin administration improve LDL-C lowering in patients requiring statin therapy?
Evening administration is recommended for simvastatin to achieve optimal LDL-C lowering, whereas atorvastatin efficacy is independent of administration time.
Answers are grounded in this paper and cite their sources.
Evening dosing optimizes simvastatin LDL-C reduction while atorvastatin timing is flexible; confirms statin-specific administration guidance from prior evidence.
OBJECTIVE: To determine the best time to administer statins for optimal lowering of low-density lipoprotein cholesterol (LDL-C) by reviewing the clinical evidence evaluating the chronobiologic effects of morning versus evening statin administration. DATA SOURCES: Using the MeSH terms HMG-CoA reductase inhibitors, statins, morning and evening dosing, and clinical trials, a literature review was conducted to identify articles in MEDLINE (1966-December 2006), International Pharmaceutical Abstracts (1970-December 2006), and IOWA Drug Information Systems (1985-December 2006). DATA SYNTHESIS: Seven English-language studies evaluating morning and evening statin administration were identified and evaluated. Based on the available data, simvastatin demonstrated a pronounced LDL-C percentage reduction with evening dosing. Although not statistically significant, a trend in the LDL-C percentage reduction favoring evening statin administration was noted with lovastatin, pravastatin, and rosuvastatin. Atorvastatin demonstrated similar LDL-C reduction regardless of administration time. With the exception of simvastatin, the trials comparing morning versus evening effects of statins on LDL-C have several significant methodologic shortcomings, including small sample size, lack of statistical power, and inappropriate exclusion criteria that did not include or did not mention drug-induced effects on lipids. CONCLUSIONS: There are sufficient data to support evening administration of simvastatin to achieve optimal lowering of LDL-C levels. Rigorous and robust trials are necessary to determine the best administration time to achieve optimal LDL-C lowering for lovastatin, pravastatin, rosuvastatin, atorvastatin, and fluvastatin.
No takes yet. Share an insight, caveat, or question.
Plakogiannis et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: